Aromasin Disease Interactions
There are 2 disease interactions with Aromasin (exemestane).
Exemestane (applies to Aromasin) osteoporosis
Moderate Potential Hazard, Moderate plausibility.
Reductions in bone mineral density (BMD) over time are seen with the use of exemestane. Women with osteoporosis or at risk of osteoporosis should have their BMD formally assessed by densitometry at treatment initiation. Monitoring for BMD loss is recommended, and treatment for it should be started as appropriate.
Exemestane (applies to Aromasin) vitamin D deficiency
Moderate Potential Hazard, Moderate plausibility.
Routine assessment of vitamin D levels prior to the start of aromatase inhibitor treatment should be performed, due to the high prevalence of vitamin D deficiency in women with early breast cancer. Women with vitamin D deficiency should receive supplementation.
Aromasin drug interactions
There are 94 drug interactions with Aromasin (exemestane).
Report options
More about Aromasin (exemestane)
- Aromasin consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (24)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
